Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...
Like a champion boxer on the ropes, Bristol-Myers Squibb (NYSE: BMY) finds itself in a challenging position. Specifically, ...
Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...
Legacy Private Trust Co. lifted its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.3% during the 4th quarter, ...
International Assets Investment Management LLC cut its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 98.4% ...
Bristol-Myers Squibb Company (BMY) is a global biopharma company ... In Q3 2024, BMY reported $11.9 billion in revenue, an 8% year-over-year increase. Key drugs like Opdivo and Eliquis continued to ...
"" class="type:primaryImage wp-post-image" height="1280" src=" width="720" data-uuid="f15a9b71-00a0-392c-b74f-a8e400fa8aa8"> ...
January is “National Radon Action Month” and state and local health departments are encouraging everyone to test their homes ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.